Results 81 to 90 of about 15,255 (159)

Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC Populations. [PDF]

CPT Pharmacometrics Syst Pharmacol
Chen J, Wada R, Zhang N, Graupner V, Morris S, Hu Y, Zhang W, Kassir N, Wu B, Chan P.   +9 more
europepmc   +1 more source

The efficacy and safety of metronomic vinorelbine combined with anlotinib in HER2-negative advanced breast cancer: a prospective, single-arm clinical study. [PDF]

Transl Breast Cancer Res
Wang X, Yang T, Zhang J, Yang J, Gong R, Liu S, Xue Y.   +6 more
europepmc   +1 more source

Comparison of the effects of different types of treatment protocols on the median and overall survival rates of non-small cell lung cancer patients: A real-world retrospective study. [PDF]

PLoS One
Siahmansur TJ.
europepmc   +1 more source

Extracellular vesicles shed by multidrug resistant cells contribute to the identification of SRC inhibitors as chemosensitizers in non-small cell lung cancer. [PDF]

Cancer Drug Resist
Polónia B, Xavier CPR, Peixoto da Silva S, Riganti C, Vasconcelos MH.   +4 more
europepmc   +1 more source

Vinorelbine enhances the efficacy of oncolytic vaccinia virus in a preclinical model of ovarian high-grade serous carcinoma. [PDF]

Mol Ther Oncol
Drymiotou S, Queval CJ, Tyson KE, Sheach LA, Postigo A, Rosa ID, Ennis DP, Howell M, McNeish IA, Way M.   +9 more
europepmc   +1 more source

Atezolizumab Combined With Cisplatin Plus Vinorelbine as Adjuvant Therapy for Completely Resected NSCLC With <i>EGFR</i> Mutation (West Japan Oncology Group 11719L: ADJUST Study). [PDF]

JTO Clin Res Rep
Shibaki R, Akamatsu H, Okada M, Murotani K, Osuga M, Nishino K, Murakami S, Wakuda K, Mitsudomi T, Tada H, Yoshimura K, Koh Y, Yamamoto N.   +12 more
europepmc   +1 more source

Survival in Men Treated for Lung Cancer: A Single-Center Retrospective Cohort Study in Poland. [PDF]

Healthcare (Basel)
Królikowska-Jerużalska M, Kurkiewicz M, Moździerz A, Rzepecka-Stojko A, Stojko J.   +4 more
europepmc   +1 more source

Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis. [PDF]

Cancers (Basel)
Pelliccia S, Banchi M, De Marchi L, Cencini E, Seimonte C, Fabbri A, Nunzi A, Destefano S, Bocci G, Cox MC.   +9 more
europepmc   +1 more source

Metronomic (mCHT) vs standard (sCHT) chemotherapy as first-line treatment in HR+/HER2- Metastatic Breast Cancer (MBC) patients following failure of endocrine treatments. The matched control VICTOR-15 study. [PDF]

BMC Cancer
Cazzaniga ME, Galimberti S, Pepe FF, Cogliati V, Sandretti F, Capici S.   +5 more
europepmc   +1 more source

MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer. [PDF]

ESMO Open
Borcoman E, Hervieu A, Cropet C, Coquan E, Guigay J, Rolland F, Bernadach M, Charafe E, Legrand F, Dassé E, Le Tourneau C, Gonçalves A.   +11 more
europepmc   +1 more source